Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Absolute risk models for subtypes of breast cancer.

Gail MH, Anderson WF, Garcia-Closas M, Sherman ME.

J Natl Cancer Inst. 2007 Nov 21;99(22):1657-9. Epub 2007 Nov 13. No abstract available.

PMID:
18000214
[PubMed - indexed for MEDLINE]
Free Article
2.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
[PubMed - indexed for MEDLINE]
Free Article
3.

Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Chu DZ.

J Natl Cancer Inst. 2008 Apr 16;100(8):596-7. doi: 10.1093/jnci/djn077. Epub 2008 Apr 8. No abstract available.

PMID:
18398103
[PubMed - indexed for MEDLINE]
Free Article
4.

Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Byers T, Trujillo S, Hines L.

J Natl Cancer Inst. 2008 Apr 16;100(8):596. doi: 10.1093/jnci/djn078. Epub 2008 Apr 8. No abstract available.

PMID:
18398102
[PubMed - indexed for MEDLINE]
Free Article
5.

Validation of a breast cancer risk prediction model developed for Black women.

Boggs DA, Rosenberg L, Pencina MJ, Adams-Campbell LL, Palmer JR.

J Natl Cancer Inst. 2013 Mar 6;105(5):361-7. doi: 10.1093/jnci/djt008. Epub 2013 Feb 14.

PMID:
23411594
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Racial differences in breast cancer trends in the United States (2000-2004).

Pfeiffer RM, Mitani A, Matsuno RK, Anderson WF.

J Natl Cancer Inst. 2008 May 21;100(10):751-2. doi: 10.1093/jnci/djn112. Epub 2008 May 13. No abstract available.

PMID:
18477805
[PubMed - indexed for MEDLINE]
Free Article
7.

Breast cancer heterogeneity: a mixture of at least two main types?

Anderson WF, Matsuno R.

J Natl Cancer Inst. 2006 Jul 19;98(14):948-51. No abstract available.

PMID:
16849671
[PubMed - indexed for MEDLINE]
Free Article
8.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

PMID:
18812550
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L.

J Natl Cancer Inst. 2007 Dec 5;99(23):1782-92. Epub 2007 Nov 27. Erratum in: J Natl Cancer Inst. 2008 Aug 6;100(15):1118. J Natl Cancer Inst. 2008 Mar 5;100(5):373.

PMID:
18042936
[PubMed - indexed for MEDLINE]
Free Article
10.

Advanced breast cancer in young women.

Peres J.

J Natl Cancer Inst. 2013 Sep 4;105(17):1257-8. doi: 10.1093/jnci/djt245. Epub 2013 Aug 16. No abstract available.

PMID:
23956454
[PubMed - indexed for MEDLINE]
Free Article
11.

Re: Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Foulkes WD.

J Natl Cancer Inst. 2004 Jul 7;96(13):1040-1; author reply 1041. No abstract available.

PMID:
15240792
[PubMed - indexed for MEDLINE]
Free Article
12.

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J; Danish Breast Cancer Cooperative Group.

J Clin Oncol. 2008 Mar 20;26(9):1419-26. doi: 10.1200/JCO.2007.14.5565. Epub 2008 Feb 19.

PMID:
18285604
[PubMed - indexed for MEDLINE]
Free Article
13.

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L.

J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. doi: 10.1093/jnci/djn079. Epub 2008 Apr 8. No abstract available.

PMID:
18398101
[PubMed - indexed for MEDLINE]
Free Article
14.

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

Anderson BO.

J Natl Cancer Inst. 2007 Dec 5;99(23):1815-6; author reply 1816-7. Epub 2007 Nov 27. No abstract available.

PMID:
18042937
[PubMed - indexed for MEDLINE]
Free Article
15.

Factors predictive of response to hormone therapy in breast cancer.

Rastelli F, Crispino S.

Tumori. 2008 May-Jun;94(3):370-83. Review.

PMID:
18705406
[PubMed - indexed for MEDLINE]
16.

Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.

Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A.

Int J Cancer. 2009 Oct 1;125(7):1663-70. doi: 10.1002/ijc.24460.

PMID:
19452528
[PubMed - indexed for MEDLINE]
17.

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE.

Breast Cancer Res. 2008;10(5):R86. doi: 10.1186/bcr2156. Epub 2008 Oct 16.

PMID:
18925950
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women.

Lin J, Lee IM, Cook NR, Selhub J, Manson JE, Buring JE, Zhang SM.

Am J Clin Nutr. 2008 Mar;87(3):734-43.

PMID:
18326613
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.

Chen WY, Colditz GA.

Nat Clin Pract Oncol. 2007 Jul;4(7):415-23. Review.

PMID:
17597706
[PubMed - indexed for MEDLINE]
20.

Breast cancer single-nucleotide polymorphisms: statistical significance and clinical utility.

Offit K.

J Natl Cancer Inst. 2009 Jul 15;101(14):973-5. doi: 10.1093/jnci/djp184. Epub 2009 Jun 30. No abstract available.

PMID:
19567420
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk